1. Home
  2. VYGR vs PKBK Comparison

VYGR vs PKBK Comparison

Compare VYGR & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • PKBK
  • Stock Information
  • Founded
  • VYGR 2013
  • PKBK 1999
  • Country
  • VYGR United States
  • PKBK United States
  • Employees
  • VYGR N/A
  • PKBK N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • PKBK Major Banks
  • Sector
  • VYGR Health Care
  • PKBK Finance
  • Exchange
  • VYGR Nasdaq
  • PKBK Nasdaq
  • Market Cap
  • VYGR 232.4M
  • PKBK 269.2M
  • IPO Year
  • VYGR 2015
  • PKBK N/A
  • Fundamental
  • Price
  • VYGR $3.99
  • PKBK $22.72
  • Analyst Decision
  • VYGR Strong Buy
  • PKBK
  • Analyst Count
  • VYGR 7
  • PKBK 0
  • Target Price
  • VYGR $16.17
  • PKBK N/A
  • AVG Volume (30 Days)
  • VYGR 468.8K
  • PKBK 19.1K
  • Earning Date
  • VYGR 11-10-2025
  • PKBK 10-22-2025
  • Dividend Yield
  • VYGR N/A
  • PKBK 3.14%
  • EPS Growth
  • VYGR N/A
  • PKBK 21.56
  • EPS
  • VYGR N/A
  • PKBK 2.83
  • Revenue
  • VYGR $31,316,000.00
  • PKBK $71,766,000.00
  • Revenue This Year
  • VYGR N/A
  • PKBK N/A
  • Revenue Next Year
  • VYGR $107.10
  • PKBK N/A
  • P/E Ratio
  • VYGR N/A
  • PKBK $8.09
  • Revenue Growth
  • VYGR N/A
  • PKBK 13.64
  • 52 Week Low
  • VYGR $2.65
  • PKBK $16.94
  • 52 Week High
  • VYGR $7.44
  • PKBK $23.87
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 41.99
  • PKBK 69.09
  • Support Level
  • VYGR $3.81
  • PKBK $21.25
  • Resistance Level
  • VYGR $4.30
  • PKBK $22.30
  • Average True Range (ATR)
  • VYGR 0.26
  • PKBK 0.40
  • MACD
  • VYGR -0.01
  • PKBK 0.12
  • Stochastic Oscillator
  • VYGR 38.14
  • PKBK 95.21

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About PKBK Parke Bancorp Inc.

Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.

Share on Social Networks: